Article Details

Enanta Sues Pfizer For Patent Infringement in COVID-19 Antiviral Paxlovid - BioSpace

Retrieved on: 2022-06-22 16:37:29

Tags for this article:

Click the tags to see associated articles and topics

Enanta Sues Pfizer For Patent Infringement in COVID-19 Antiviral Paxlovid - BioSpace. View article details on HISWAI: https://www.biospace.com/article/enanta-calls-out-pfizer-for-patent-infringement-in-covid-19-drug-component/

Excerpt

Enanta filed a patent infringement lawsuit against Pfizer for the latter's alleged use of its proprietary antiviral component in producing the ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up